Dr. Xianting Ding is an Associate Professor of Biomedical Engineering. He received his Ph.D. degree from Department of Mechanical Engineering at UCLA in 2012. He participated in the early investigation and development for 3 international research centers, including Institute for Cell Mimetic Space Exploration (CMISE, funded by NASA), Center for Cell Control (CCC, funded by NIH) and Institute for Personalized Medicine (IPM, funded by Chinese Central Organization Department). He has published 20 peer reviewed journal papers and filed 6 patent applications. He is now leading 16 combinatorial-drug optimization related international projects. His research interests focus on developing personalized medicine and individualized therapy, including: 1) developing bio-sensors for early detection of cancer, infectious disease, metabolic diseases, age-related diseases, cardiovascular diseases, based on cellular electrochemical, impedance, mechanical and photonic signaling; 2) developing personalized treatment; optimizing drug combinations; studying drugdrug interactions; building up models for bio-complex systems, based on Feedback System Control (FSC), Microfluidics and Bio-MEMS; and 3) traditional Chinese Medicine modernization, extraction, purification, and re-combination for treating ischemia, osteoporosis and depression.